A new study from researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood ...

Wake Forest University School of Medicine researchers found that just 3½ years of intensive blood pressure control can significantly reduce the risk of mild cognitive impairment or dementia.

Intensive blood pressure control for adults with hypertension and high cardiovascular risk can reduce the risk of mild ...

"If you look at all the things we know that may be associated with the risk of developing dementia, the two strongest are age ...

During the years of follow-up, 248 of those who had undergone intensive blood pressure treatment were determined to have probable dementia or mild cognitive impairment, compared with 293 ...

Tight control over blood pressure can protect brain health against aging. Seniors had reduced risk of mild cognitive ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...

The US Food and Drug Administration (FDA) has approved Eisai and Biogen’s Supplemental Biologics License Application for once ...

In an extended follow-up study, intensive blood pressure control is associated with reductions in the rate of cogniti ...

Seniors whose cholesterol levels spike and plummet year-to-year could be at increased risk of dementia and failing brain ...

Biogen (BIIB) and Eisai announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...

BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's Supplemental Biologics License Application ...